Strategic Partnerships Lead for Digital Innovation

ictjob.be is seeking a seasoned Partnerships leader to identify, evaluate, and cultivate a network of external partners aligned with DT strategic objectives. The role will translate strategic needs into tangible partnership opportunities and manage a portfolio of alliances to accelerate innovation across Digital Technology and the broader organization.You...

argenx SE is seeking a DT Business Lead - Research based in Gent, Belgium. This role leads the strategic technology partnership across Research, driving innovation and cohesive technology solutions that support the R&D lifecycle.The ideal candidate will have an advanced degree in Life Sciences or BioInformatics and over 6 years of experience in technology...

Company Overviewargenx is a global immunology company focused on developing therapies for severe autoimmune diseases. We bring scientific innovation to patients worldwide through a pipeline of antibody‑based medicines, including VYVGART®, our first‑in‑class neonatal Fc receptor blocker.Purpose of the FunctionThe DT Strategic Partnerships Lead will...

This role will be responsible for identifying, evaluating, and cultivating a network of high-impact external partners that align with our DT strategic objectives. This position will define and implement engagement models that drive co-creation and deliver sustained, mutual value, translating the company's strategic needs into tangible partnership...

argenx is expanding its international Digital Technology team and seeks a Global DT Lead Development to serve as the strategic technology leader for Development capabilities. You will define the technology vision, roadmap, and value delivery enabling clinical development and data-driven decisions across the portfolio.The role translates scientific and...

## DT Business Lead - ResearchApplylocations: Gent, Belgiumtime type: Full timeposted on: Posted 2 Days Agojob requisition id: REQ-4360*Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...